1999
DOI: 10.1016/s0041-1345(98)01679-0
|View full text |Cite
|
Sign up to set email alerts
|

Effects of fatty infiltration of the graft on the outcome of living-related liver transplantation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
54
2
1

Year Published

2000
2000
2016
2016

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 85 publications
(57 citation statements)
references
References 1 publication
0
54
2
1
Order By: Relevance
“…(32) Grafts with moderate steatosis (30-59%) can be used, provided they are well allocated to recipients (i.e., recipients free from other risk factors). (34,35) Transplantation of grafts with severe (over 60%) steatosis is limited to a few centers; most groups choose not to use such grafts out of increased EAD and PNF risk concerns. (35,36) Given the limited availability of grafts compared to organ demands, several transplant centers use marginal donors.…”
Section: Risk Factors For Early Allograft Dysfunction and Primary Nonmentioning
confidence: 99%
See 2 more Smart Citations
“…(32) Grafts with moderate steatosis (30-59%) can be used, provided they are well allocated to recipients (i.e., recipients free from other risk factors). (34,35) Transplantation of grafts with severe (over 60%) steatosis is limited to a few centers; most groups choose not to use such grafts out of increased EAD and PNF risk concerns. (35,36) Given the limited availability of grafts compared to organ demands, several transplant centers use marginal donors.…”
Section: Risk Factors For Early Allograft Dysfunction and Primary Nonmentioning
confidence: 99%
“…(34,35) Transplantation of grafts with severe (over 60%) steatosis is limited to a few centers; most groups choose not to use such grafts out of increased EAD and PNF risk concerns. (35,36) Given the limited availability of grafts compared to organ demands, several transplant centers use marginal donors. Such donors are defined as expanded criteria donors according to the following: age ≥60 years, body mass index >27 to 30kg/m 2 , macrovesicular steatosis ≥30%, length of stay at ICU >4 to 5 days, use of vasoactive drugs (dopamine at doses >10μ/kg/minute or any other catecholamine, regardless of dosage), longstanding hypotension (over 1 hour), serum sodium levels >150-155mmol/L, cold ischemia time >8 hours, hot ischemia time >40-45 minutes, controlled sepsis, serum creatinine levels >1.2mg/dL, history of alcoholism, serum bilirubin, ALT and AST levels >2.0mg/dL, >170IU/L and >140IU/L, respectively.…”
Section: Risk Factors For Early Allograft Dysfunction and Primary Nonmentioning
confidence: 99%
See 1 more Smart Citation
“…25 In animal models, the low-choline methionine diet produces periportal infiltration, whereas the cholesterol model used by Seifalian et al 26 induces central lobular change. 27,28 These regional differences may reflect zonal biochemical variations within liver sinusoids.…”
Section: Experimental Models Of Fatty Livermentioning
confidence: 99%
“…31 In another analysis of grafts from living donors with varying degrees of steatosis, only severe steatosis greater than 60% was associated with poor graft function and outcome. 69 Mild to moderate steatosis does not mandate donor exclusion, but significant steatosis may represent undis- …”
Section: Steatosis In Graftsmentioning
confidence: 99%